Q-omics provides the consensus-scored LONRF2P4 profile across patient tissues and cancer cell-line models. LONRF2P4 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, LONRF2P4 RNA expression shows 2,499 significant gene co-expression associations, with the highest sampling consensus in LGG. Together, these results highlight BLCA, and LGG as cancer lineages where LONRF2P4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LONRF2P4 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes LONRF2P4 survival associations across molecular data types. LONRF2P4 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

LONRF2P4 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	BLCA (54)	view →

This table ranks reproducible LONRF2P4 RNA expression–survival associations across cancer types. High LONRF2P4 expression shows unfavorable associations in BLCA, PCPG, THCA and OV, but favorable associations in STAD and ESCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for LONRF2P4 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.359	0.721	<.001	54	view →
STAD	OS	Tertile	II,III,IV	1.000	0.633	.006	39	view →
ESCA	OS	Tertile	III,IV	0.811	0.363	.044	18	view →
PCPG	OS	Tertile	All	0.762	0.975	<.001	18	view →
THCA	OS	Tertile	All	0.911	0.982	.005	6	view →
OV	OS	Tertile	II,III,IV	0.677	0.848	.046	6	view →

Pink = unfavorable, green = favorable. all 7 lineages →

LONRF2P4-BLCA (OS)

Kaplan–Meier survival curve for LONRF2P4 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with LONRF2P4 in patient tissues and cancer cell lines. In patient samples, LONRF2P4 shows the broadest associations at the RNA and protein expression levels, with LGG recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	2,499	LGG (413)	view →
Function (RNA)	1,914	ESCA (638)	view →